IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RXI Pharmaceuticals Corp New

CUSIP: 74979C113 | 6 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2017

Anson Funds Management LPA2,221,722
0.3% of portfolio›$1.2K
Susquehanna International Group, LLP2,216,855
0.0% of portfolio›$288
Sabby Management, LLC2,100,797
0.0% of portfolio›$273
Ladenburg Thalmann Financial Services Inc30,000
0.0% of portfolio›$4
StyleTurnoverLocationFiled
Anson Funds Management LPActivist
2,221,722$1.2K0.3%GARPVery HighDallas, TX2018-02-14
Susquehanna International Group, LLP
2,216,855$2880.0%GrowthHighBala Cynwyd, PA2018-02-14
Sabby Management, LLC
2,100,797$2730.0%GrowthVery HighMiami Beach, FL2018-02-15
Ladenburg Thalmann Financial Services Inc
30,000$40.0%N/AN/AMiami, FL2018-02-14